ESMO 2021: Adding Investigational Plinabulin to Docetaxel Boosts Efficacy, Reduces Toxicity in Pretreated Non-Small Cell Lung Cancer
The combination was studied in patients without EGFR mutations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.